Press "Enter" to skip to content

New patent expiration for Janssen Pharms drug INVEGA SUSTENNA


Annual Drug Patent Expirations for INVEGA+SUSTENNA
Annual Drug Patent Expirations for INVEGA+SUSTENNA

Invega Sustenna is a drug marketed by Janssen Pharms
and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has twenty-one patent family members in sixteen countries.

The generic ingredient in INVEGA SUSTENNA is paliperidone palmitate. One supplier is listed for this compound. Additional details are available on the paliperidone palmitate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!